← All patents

US20050004044A1

Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en-22-one 16-0-(2 …

University of Texas System

Abstract

The present invention concerns methods for treating pancreatic cancers, leukemias, colon cancers, malignant gliomas and other brain tumors, and ovarian cancers which comprise providing to an individual compositions comprising an orsaponin such as OSW-1 or its derivatives such as 17-deoxyorsaponin.

University
University of Texas System
Assignee
The University Of Texas System
Inventor
Peng Huang
Priority date
April 07, 2003
Filing date
April 07, 2004
Publication date
January 06, 2005
Language
en
Metadata fetched
August 28, 2026 23:58